Paper shapes forming a peptide chain beside an open reference card
Name before claims

Orientation

Before you start: name the thing clearly

Read this first Plain-language handbook

The short version

Thymosin alpha-1 is a peptide made from 28 amino acids, the small units that link together to make proteins.

The manufactured form used as a medicine in some countries is called thymalfasin.

Thymosin alpha-1 is not thymosin beta-4 or TB-500; those are different peptides with similar names.

What the name does and does not tell you

The word peptide describes a short chain of protein building blocks; by itself, it says nothing about approval, safety, or legality.

That is why a page that talks only about “peptide therapy” has not yet answered the useful question: what exact substance and preparation is being discussed?

Thymosin alpha-1 is thought to make some of the body’s infection-fighting cells more active, but exactly how it works in people is still not settled.

An idea about how a drug acts is not proof that it helps patients. The Fact check page covers what the studies found.

Words to pin down

  • The compound: the specific peptide named in an offer.
  • Thymalfasin: the name used for a manufactured version.
  • Compounded preparation: medicine made to order by a pharmacy or clinician rather than supplied as a ready-made product.
  • Clinician: the doctor, nurse practitioner, or other licensed professional who examines you and can prescribe.
  • Preparation: the actual product you would receive, such as a shot or a spray, and what is in it.
  • Telehealth: a way to receive care at a distance, by video or phone, not a type of medicine.

A clean opening question

Ask: “What exact compound and preparation are we discussing?” That one question moves the talk away from a broad sales word like “peptide therapy” and onto the actual medicine you would get.